Sequoia China-Backed AI Startup Xtalpi To Partner With Pharma Giant Eli Lilly In $250 Million Novel Drug Deal
Xtalpi said the drug candidates will target a disease that currently has no medicine available.
Tags : ai startup seqouia china seqouia ai xtalpi eli lilly shares eli lilly stock ai drug discovery ai drug ai fundraising China ai
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.